Skip to main content
. 2022 Feb 11;14(4):903. doi: 10.3390/cancers14040903

Figure 7.

Figure 7

Illustrative diagram displaying this study’s proposed mechanism by which tipifarnib combats therapeutic resistance within the RCC microenvironment.